Daiichi Sankyo has deferred its proposed open offer to acquire an additional 20 per cent stake in Ranbaxy, citing a delay in approvals from market regulator Sebi. Ranbaxy Managing Director and CEO Malvinder Singh says that a new date will be announced soon.